Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT

Solomon Tesfaye, Gordon Sloan, Jennifer Petrie, David White, Mike Bradburn, Tracey Young, Satyan Rajbhandari, Sanjeev Sharma, Gerry Rayman, Ravikanth Gouni, Uazman Alam, Steven A Julious, Cindy Cooper, Amanda Loban, Katie Sutherland, Rachel Glover, Simon Waterhouse, Emily Turton, Michelle Horspool, Rajiv Gandhi, Deirdre Maguire, Edward Jude, Syed Haris Ahmed, Prashanth Vas, Christian Hariman, Claire McDougall, Marion Devers, Vasileios Tsatlidis, Martin Johnson, Didier Bouhassira, David L Bennett, Dinesh Selvarajah

Open source

DOI
10.3310/rxuo6757
Published
2022-10
Container
Health Technology Assessment
Publisher
National Institute for Health and Care Research
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3310/rxuo6757,
  title = {Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT},
  author = {Solomon Tesfaye and Gordon Sloan and Jennifer Petrie and David White and Mike Bradburn and Tracey Young and Satyan Rajbhandari and Sanjeev Sharma and Gerry Rayman and Ravikanth Gouni and Uazman Alam and Steven A Julious and Cindy Cooper and Amanda Loban and Katie Sutherland and Rachel Glover and Simon Waterhouse and Emily Turton and Michelle Horspool and Rajiv Gandhi and Deirdre Maguire and Edward Jude and Syed Haris Ahmed and Prashanth Vas and Christian Hariman and Claire McDougall and Marion Devers and Vasileios Tsatlidis and Martin Johnson and Didier Bouhassira and David L Bennett and Dinesh Selvarajah},
  year = {2022},
  journal = {Health Technology Assessment},
  doi = {10.3310/rxuo6757},
  url = {https://doi.org/10.3310/rxuo6757}
}

RIS

TY  - JOUR
TI  - Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT
AU  - Solomon Tesfaye
AU  - Gordon Sloan
AU  - Jennifer Petrie
AU  - David White
AU  - Mike Bradburn
AU  - Tracey Young
AU  - Satyan Rajbhandari
AU  - Sanjeev Sharma
AU  - Gerry Rayman
AU  - Ravikanth Gouni
AU  - Uazman Alam
AU  - Steven A Julious
AU  - Cindy Cooper
AU  - Amanda Loban
AU  - Katie Sutherland
AU  - Rachel Glover
AU  - Simon Waterhouse
AU  - Emily Turton
AU  - Michelle Horspool
AU  - Rajiv Gandhi
AU  - Deirdre Maguire
AU  - Edward Jude
AU  - Syed Haris Ahmed
AU  - Prashanth Vas
AU  - Christian Hariman
AU  - Claire McDougall
AU  - Marion Devers
AU  - Vasileios Tsatlidis
AU  - Martin Johnson
AU  - Didier Bouhassira
AU  - David L Bennett
AU  - Dinesh Selvarajah
PY  - 2022
JO  - Health Technology Assessment
DO  - 10.3310/rxuo6757
UR  - https://doi.org/10.3310/rxuo6757
ER  - 

APA

Tesfaye, S., Sloan, G., Petrie, J., White, D., Bradburn, M., Young, T., Rajbhandari, S., Sharma, S., Rayman, G., Gouni, R., Alam, U., Julious, S. A., Cooper, C., Loban, A., Sutherland, K., Glover, R., Waterhouse, S., Turton, E., Horspool, M., Gandhi, R., Maguire, D., Jude, E., Ahmed, S. H., Vas, P., Hariman, C., McDougall, C., Devers, M., Tsatlidis, V., Johnson, M., Bouhassira, D., Bennett, D. L., & Selvarajah, D. (2022). Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technology Assessment. https://doi.org/10.3310/rxuo6757

Source records